Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

82.28 +0.91 (+1.12%)
Streaming Delayed Price Updated: 12:17 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
62 63 Next >
Breaking Update: Synergy Corp. (NASDAQ: SNYR) Powers Up FOCUSfactor Expansion – Early Movers Include ALZN, ZEO, NAOV, HTCR
Via AB Newswire
Synergy CHC Corp. (NASDAQ: SNYR) Taps Beverage Veteran to Drive FOCUSfactor’s Drink Expansion – More Stocks Inside
Via AB Newswire
Topics Economy
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position? 
Via Investor's Business Daily
Q1 Earnings Roundup: Humana (NYSE:HUM) And The Rest Of The Health Insurance Providers Segment
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Humana (NYSE:HUM) and the best and worst... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
What Does the Market Think About CVS Health?
 
Via Benzinga
Synergy CHC Corp. (NASDAQ: SNYR) Powerhouse Brand “FOCUSfactor” Driving Growth
Via AB Newswire
Wednesday's session: top gainers and losers in the S&P500 index
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Stay informed with the top movers within the S&P500 index on Wednesday.
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
"If Walmart Is Under Pressure to Raise Prices, It's Going to Have Broader Effects on the Economy."
Via The Motley Fool
Topics Earnings Economy World Trade
2 Value Stocks with Exciting Potential and 1 to Steer Clear Of
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Palantir: The Only Cathie Wood Pick Among S&P 500's Top Performers
NRG Energy Inc leads S&P 500's 2024 leaderboard with 70% YTD gain. Palantir follows with 64% surge, only stock from Cathie Wood's ARK funds in top performers. 
Via Benzinga
Topics Stocks
Benzinga Bulls And Bears: Alphabet, L3Harris, Target — And Latest Tariff News Roils Markets
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
What the Options Market Tells Us About CVS Health
 
Via Benzinga
8 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Microsoft Clears Major Hurdle As FTC Ends Effort To Block Activision Merger
The Ninth Circuit affirmed a decision denying the FTC's application to block Microsoft's acquisition of Activision Blizzard. The FTC dropped the case and Trump's personnel changes may impact future... 
Via Benzinga
Topics Government
FTC Scraps PepsiCo Price Discrimination Case In 3-0 Vote, Marking Major Shift As Trump-Era Leadership Reverses Biden Crackdown
The Federal Trade Commission voted 3-0 Thursday to dismiss a lawsuit against PepsiCo Inc. that accused the beverage giant of offering preferential pricing to major retailers, marking a significant... 
Via Benzinga
Topics Government Lawsuit
Which S&P500 stocks are moving before the opening bell on Thursday?
As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses. 
Via Chartmill
UnitedHealth, CVS Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
 
Via Benzinga
Wegovy, Zepbound Just Got Cheaper: Cigna Sets $200 Monthly Limit For Weight-Loss Drug Users
Cigna’s Evernorth has reached agreements with Eli Lilly and Novo Nordisk to reduce prices for GLP-1 weight-loss drugs Wegovy and Zepbound 
Via Stocktwits
Humana, UnitedHealth, CVS Slide As CMS Targets Medicare Overpayments In ‘Aggressive’ Audit Plan
US healthcare stocks came under pressure after CMS said it would expand Medicare Advantage audits and partner with the HHS Inspector General to recover past overpayments. 
Via Stocktwits
Health Care Stocks Like UnitedHealth, CVS Tank On Wednesday: Here's Why
Health care stocks are tanking in Wednesday's extended trading after CMS announced a significant expansion of its auditing efforts for Medicare Advantage (MA) plans. 
Via Benzinga
CVS Stock Analysis: Buy, Hold, or Sell?
Via The Motley Fool
The Best Healthcare Stocks: UnitedHealth Stock vs. CVS Stock
Via The Motley Fool
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket. 
Via Benzinga
Topics Government
MarketBeat Week in Review – 05/12 - 05/16
Stocks had a strong week on a potential U.S.-China trade deal and cooler inflation data, but volatility may remain as investors shift focus to tax cuts 
Via MarketBeat
Topics Artificial Intelligence Economy Government
Discover which S&P500 stocks are making waves on Friday.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session. 
Via Chartmill
9 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
CVS, Walgreens To Buy Pharmacy Assets From Rite Aid Corp: Retail Sentiment Brightens
The U.S. Bankruptcy Court for the District of New Jersey must approve the transactions, and it is currently scheduled to conduct a hearing to approve the sales on May 21, 2025. 
Via Stocktwits
Topics Bankruptcy
Is It Time to Buy the Dip in Novo Nordisk Stock?
Novo Nordisk stock is down nearly 50% in 2025 as competition in the GLP-1 space continues to mount, but the fundamental case for the NVO stock is growing 
Via MarketBeat
Topics Government
CVS Q1 Earnings Call: Guidance Raised Amid Segment Shifts and Pharmacy Innovation
Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q1 CY2025, with sales up 7% year on year to $94.59 billion. Its non-GAAP profit of $2.25 per share was... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
62 63 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.